Protagonist Therapeutics (PTGX) Q1 2026 Earnings

26FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.69
-0.52
-0.36
-0.19

Details

Expected EPS
-0.567185
Actual EPS
-0.69
Surprise EPS
-0.12
Surprise Percent
+21.65%

Description

Protagonist Therapeutics (PTGX) has reported earnings of -0.69 per share for Q1 2026.

0 Comments

Share your thoughts